Effects of granulocyte colony-stimulating factor in cirrhotic rats with pneumococcal pneumonia

Journal of Infectious Diseases

Volumn 174, Issue 1, 1996, Pages 225-228

  Preheim, Laurel C ^a,b   Snitily, Mary U ^a   Gentry, Martha J ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA NEBRASKA WESTERN IOWA HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPIRATION, PUNCTURE AND SUCTION; CONTROLLED STUDY; LIVER CIRRHOSIS; LOBAR PNEUMONIA; LUNG LAVAGE; MORTALITY; NONHUMAN; PHAGOCYTOSIS; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; RAT; STREPTOCOCCUS PNEUMONIA;

EID: 0030054812     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/174.1.225     Document Type: Article

References (15)

1. Mufson MA, Kruss DM, Wasil RE, Metzger WI. Capsular types and outcome of bacteremic pneumococcal disease in the antibiotic era. Arch Intern Med 1974;134:505-10.
2. Gransden WR, Eykyn SJ, Phillips I. Pneumococcal bacteremia: 325 episodes diagnosed at St. Thomas's Hospital. Br Med J 1985;290:505-8.
3. Rajkovic IA, Williams R. Abnormalities of neutrophil phagocytosis, intracellular killing, and metabolic activity in alcoholic cirrhosis and hepatitis. Hepatology 1986;6:252-62.
4. Garcia-Gonzalez M, Boixeda D, Herrero D, Burgaleta C. Effect of granulocyte-macrophage colony-stimulating factor on leukocyte function in cirrhosis. Gastroenterology 1993;105:527-31.
5. Dale DC, Liles WC, Summer WR, Nelson S. Review: granulocyte colony-stimulating factor - role and relationships in infectious diseases. J Infect Dis 1995;172:1061-75.
6. Mellencamp MA, Preheim LC. Pneumococcal pneumonia in a rat model of cirrhosis: effects of cirrhosis on pulmonary defense mechanisms against Streptococcus pneumoniae. J Infect Dis 1991;163:102-8.
7. Preheim LC, Gentry MJ, Snitily MU. Pulmonary recruitment, adherence, and chemotaxis of neutrophils in a rat model of cirrhosis and pneumococcal pneumonia. J Infect Dis 1991;164:1203-6.
8. Preheim LC, Mellencamp MA, Snitily MU, Gentry MJ. Effect of cirrhosis on the production and efficacy of pneumococcal capsular antibody in a rat model. Am Rev Respir Dis 1992;146:1054-8.
9. Gentry MJ, Snitily MU, Preheim LC. Phagocytosis of Streptococcus pneumoniae measured in vitro and in vivo in a rat model of carbon tetrachloride - induced liver cirrhosis. J Infect Dis 1995;171:350-5.
10. Gurakar A, Fagiuoli S, Gavaler JS, et al. The use of granulocyte-macrophage colony-stimulating factor to enhance hematologic parameters of patients with cirrhosis and hypersplenism. J Hepatol 1994;21:582-6.
11. Roilides E, Walsh TJ, Pizzo PA, Rubin M. Granulocyte colony-stimulating factor enhances the phagocytic and bactericidal activity of normal and defective human neutrophils. J Infect Dis 1991;163:579-83.
12. Tilg H, Wilmer A, Vogel W, et al. Serum levels of cytokines in chronic liver diseases. Gastroenterology 1992;103:264-74.
13. Ruiz AD, Perez JLS, Martinez GL, Calvin JG, Extremera BG, Gea FG. Tumour necrosis factor, interleukin-1, and interleukin-6 in alcoholic cirrhosis. Alcohol Alcohol 1993;28:319-23.
14. Tuomanen EI, Austrian R, Masure HR. Pathogenesis of pneumococcal infection. N Engl J Med 1995;332:1280-4.
15. Cundell DR, Gerard NP, Gerard C, Idanpaan-Helkklla I, Toumanen EI. Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor. Nature 1995;377:435-8.